Evidence that cortical dopamine is a co-transmitter in noradrenergic neurons

Current Psychiatry Reviews

Volumn 2, Issue 1, 2006, Pages 103-109

  Devoto, Paola ^a   Flore, Giovanna ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cerebral cortex; Co release; Dopamine; Microdialysis; Noradrenaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; MIRTAZAPINE; NEUROLEPTIC AGENT; NORADRENALIN; NORADRENALIN TRANSPORTER; OLANZAPINE;

BRAIN CORTEX; COGNITION; DEPRESSION; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; LOCUS CERULEUS; MENTAL DISEASE; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; REVIEW;

EID: 33745820326     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340006775101463     Document Type: Review

References (73)

1. Arnsten AFT, Goldman-Rakic PS. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 1998; 55: 362-9.
2. 1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 2000; 20: 1208-15.
3. Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Nat Acad Sci USA 2003; 100: 6186-91.
4. Arnsten AFT. Adrenergic targets for the treatment of cognitive deficit in schizophrenia. Psychopharmacology 2004; 174: 25-31.
5. Arnsten AFT. Catecholamine regulation of the prefrontal cortex. J Psychopharm 1997; 11: 151-62.
6. Descarries L, Lemay B, Doucet G, Berger B. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 1987; 21: 807-24.
7. Seguela P, Watkins KC, Geffard M, Descarries L. Noradrenaline axon terminals in adult rat neocortex: an immunohistochemical analysis in serial thin sections. Neuroscience 1990; 35: 249-64.
8. 125I]iodosulpiride, a highly selective ligand. Science 1985; 228: 752-5.
9. 3H]raclopride. Proc Nat Acad Sci USA 1989; 86: 6412-6.
10. 2 receptors in the cerebral cortex of rats, cats and monkeys. J Comp Neurol 1989; 286: 409-26.
11. 2 receptors in hippocampus and parahippocampal cortex of rat, cat and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 1994; 4: 354-73.
12. 4 recetros in the rat brain - Immunocytochemical study. J Physiol Pharmacol 2000; 51: 205-21.
13. Ungertstedt U. In: Marsden, C.A. Ed, Measurement of Neurotransmitter Release In Vivo. New York Wiley 1984; 81-105.
14. Finlay JM, Smith GS. In: Bloom, F.E., Kupfer, D.J. Eds, Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press 1995; 29-40.
15. Devoto P, Flore G, Pani L, Gessa GL. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 2001; 6: 657-64.
16. Kawahara Y, Kawahara H, Westerink BHC. Comparison of the effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 1999; 360: 42-9.
17. Feenstra MGP. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Progr Brain Res 2000; 126: 133-63.
18. Murphy EK, Sved AF, Finlay JM. Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex or control or chronically stressed rats. Neuroscience 2003; 116: 1081-7.
19. Tanda G, Bassareo V, Di Chiara G. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the mt. Psychopharmacol 1996; 123: 127-30.
20. 2C receptors: a comparison with citalopram. Eur J Neurosci 2000; 12: 1079-95.
21. Devoto P, Flore G, Pira L, Longu G, Gessa GL. Mirtazapine-induced co-release of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 2004; 487: 105-11.
22. Roberts DC, Zis AP, Fibiger HC. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res 1975; 93: 441-54.
23. Darracq L, Blanc G, Glowinski J, Tassin J-P. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 1998; 18: 2729-39.
24. Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol 1998; 361: 27-33.
25. Li X-M, Perry KW, Wong DT, Bymaster FP. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacol 1998; 136: 153-61.
26. Devoto P, Flore G, Vacca G, et al. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacol 2003; 167: 79-84.
27. Pira L, Mongeau R, Pani L. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Eur J Pharmacol 2004; 504: 61-64.
28. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Local influence of endogenous epinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 1995; 65: 111-6.
29. Kawahara H, Kawahara Y, Westerink BHC. The noradrenaline-dopamine interactions in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur J Pharmacol 2001; 418: 177-86.
30. 2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J Neurochem 2004; 88: 1003-9.
31. Hertel P, Nomikos GG, Svensson TH. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol 1999; 371: 153-8.
32. Devoto P, Flore G, Longu. G, Pira L, Gessa GL. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse 2003; 50: 200-5.
33. Yamamoto BK, Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 1998; 71: 274-80.
34. Andén N-E, Grabowska M. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 1976; 39: 275-82.
35. Grenhoff J, Nisell M, Ferré S, Aston-Jones G, Svensson TH. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm 1993; 93: 11-25.
36. Aghajanian GK. In: Usdin E, Carlsson A, Dahlstrom A, Engel J Eds, Catecholamines: neuropharmacology and central nervous system - theoretical aspects. New York, Alan R. Liss 1984; 85-92.
37. 1-adrenoceptors. Nature 1985; 315: 501-13.
38. Grenhoff J, Svensson TH. Clonidine modulates dopamine cell firing in the ventral tegmental area. Eur J Pharmacol 1989; 165: 11-8.
39. Paladini CA, Williams JT. Noradrenergic inhibition of midbrain dopamine neurons. J Neurosci 2004; 24: 4568-75.
40. Horn AS. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenergic and dopaminergic neurons in rat brain homogenates. Br J Pharmacol 1973; 47: 332-8.
41. Raiteri M, Del Carmine R, Bertollini A, Levi G. Effects of sympaticomimetic amines on the synaptosomal transport of noradrenaline, dopamine, 5-hydroxytryptamine. Eur J Pharmacol 1977; 41: 133-43.
42. Carboni E, Tanda GL, Frau R, Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 1990; 55: 1067-70.
43. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 1994; 63: 195-200.
44. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mice lines. J Neurosci 2002; 22: 389-95.
45. Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995; 15: 1714-23.
46. Devoto P, Flore G, Saba P, Fà M, Gessa GL. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem 2005; 92: 368-74.
47. Westerink BH, Enrico P, Feimann J, De Vries JB. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 1998; 285: 143-154.
48. Gronier B, Perry KW, Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacol 2000; 147: 347-355.
49. Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharm 2000; 22: 642-9.
50. Pehek EA, Yamamoto BK. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem. 1994; 63: 2118-24.
51. Kuroki T, Meltzer HY, Ichikawa J. Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharm Exp Ther 1999; 288: 774-81.
52. Heidbreder CA, Foxton R, Cilia J, et al. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology 2001; 156: 338-51.
53. Moghaddam B, Bunney BS. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 1990; 54: 1755-60.
54. Zigmond RE, Schwarzschild MA, Rittenhouse AR. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorilation. Ann Rev Neurosci 1989; 12: 415-61.
55. Nakahara D, Nakamura M, Furukawa H, Furuno N. Intracranial self-stimulation increases differentially in vivo hydroxylation of tyrosine but similarly in vivo hydroxylation of tryptophan in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Res 2000; 864: 124-9.
56. Zetterstrom T, Sharp T, Collin AK, Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 1988; 148: 327-34.
57. Soares da Silva P, Garrett MC. A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC. Neuropharmacology 1990; 29: 869-74.
58. Meltzer HY, Stahl SM. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 1976; 2: 19-76.
59. Lidow MS, Williams GV, Goldman-Rakic PS. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 1998; 19: 136-40.
60. Imperato A, Angelucci L. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol Bull 1989; 25: 383-9.
61. Chen JP, Ruan D, Paredes W, Gardner EL. Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Brain Res 1992; 571: 235-41.
62. Bymaster FP, Calligaro DO, Falcone JF, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharm 1996; 14: 87-96.
63. Nutt DJ, Lalies MD, Lione LA, Hudson AL. Noradrenergic mechanism in the prefrontal cortex. J Psychopharmacol 1997; 11: 163-8.
64. 2-adrenoceptor blockade. Science 1999; 286: 105-7.
65. White FJ, Wang RY. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther 1984; 231: 275-80.
66. Imperato A, Tanda G, Frau R, Di Chiara G. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 1987; 245: 257-64.
67. Rollema H, Lu Y, Schmidt AW, Zorn SH. Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol 1997;338 :R3-R5.
68. Ichikawa J, Dai J, Meltzer HY. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res 2001; 907:151-155.
69. De Boer T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 1996; 57: 19-25.
70. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neurosci 2004; 27: 683-690.
71. Yamamoto K, Hornykiewicz O. Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharm Biol Psy 2004; 28: 913-922
72. Oades RD, Sadile GA, Sagvolden T, et al. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Develop Sci 2005; 8: 122-131.
73. Rossetti ZL, Carboni S. Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory. J Neurosci 2005; 25: 2322-2329.